Outcomes of Home Monitoring after Palliative Cardiac Surgery in Infants with Congenital Heart Disease.
10.4040/jkan.2014.44.2.228
- Author:
Sang Wha KIM
1
;
Ju Yeon UHM
;
Yu Mi IM
;
Tae Jin YUN
;
Jeong Jun PARK
;
Chun Soo PARK
Author Information
1. Department of Nursing, Asan Medical Center, Seoul, Korea. jyuhm@amc.seoul.kr
- Publication Type:Original Article ; English Abstract
- Keywords:
Telenursing;
Congenital heart defects;
Pediatric cardiac surgery;
Home monitoring
- MeSH:
Body Temperature;
Body Weight;
Caregivers/education/psychology;
Counseling;
Female;
Heart Defects, Congenital/mortality/prevention & control/*surgery;
Heart Rate;
Hospitalization;
Hotlines;
Humans;
Infant;
Infant, Newborn;
Male;
Monitoring, Physiologic/*methods;
Oxygen Consumption;
Palliative Care;
*Program Evaluation;
Prospective Studies;
Time Factors
- From:Journal of Korean Academy of Nursing
2014;44(2):228-236
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Common conditions, such as dehydration or respiratory infection can aggravate hypoxia and are associated with interstage mortality in infants who have undergone palliative surgery for congenital heart diseases. This study was done to evaluate the efficacy of a home monitoring program (HMP) in decreasing infant mortality. METHODS: Since its inception in May 2010, all infants who have undergone palliative surgery have been enrolled in HMP. This study was a prospective observational study and infant outcomes during HMP were compared with those of previous comparison groups. Parents were trained to measure oxygen saturation, body weight and feeding volume and to contact the hospital through the hotline for emergency situations. Telephone counseling was conducted by clinical nurse specialists every week post discharge. RESULTS: Forty-one infants were enrolled in HMP. Nine hundred telephone counseling sessions were conducted. Seventy-three infants required telephone triage with the most common conditions being gastrointestinal (50.7%) and respiratory symptoms (32.9%). With HMP intervention, interstage mortality decreased from 18.6% (8/43) to 9.8% (4/41) (chi2=1.15, p=.283). CONCLUSION: Results indicate that active measures and treatments using the HMP decrease mortality rates, however further investigation is required to identify various factors that contribute to hemodynamic complications during the interstage period.
